Fli-1, an ets related gene, was found to be rearranged in 75% of eryth
roleukemias induced by Friend murine leukemia virus. We have shown pre
viously that the Fli-1 gene codes fora sequence specific transcription
al activator which contains two autonomous transcriptional activation
domains, one at the amino terminal region and the other at the carboxy
terminal region. Recently human Fli-1 gene was shown to be involved i
n Ewing's sarcoma and related subtypes of primitive neuroectodermal tu
mors which share t(11;22) (q24;q12) chromosome translocation. In these
tumors the carboxyl terminal region of Fli-1 was found to be fused wi
th the amino terminal region of a putative RNA binding protein, EWS. B
ecause part of the amino terminal transcriptional activation domain of
Fli-1 was replaced with the amino terminal domain of the EWS (NTD-EWS
) which shares homology with RNA polymerase II, it was speculated that
NTD-EWS may interfere with RNA pol II function. Alternatively, NTD-EW
S could also contribute to the transcriptional activation function of
EWS/Fli-1 chimeric protein by providing either a modulatory/regulatory
domain or a novel transcriptional activation domain. Here we show tha
t EWS/Fli-1 chimeric protein functions as a transcriptional activator.
Deletion analysis reveals that the EWS domain functions as a modulato
ry/regulatory domain for the transcriptional activation properties of
the carboxy terminal transcriptional activation domain of EWS/Fli-1. W
e therefore propose that replacement of the amino terminal transcripti
onal activation domain of the Fli-1 protein with the regulatory domain
of NTD-EWS results in the activation of the carboxy terminal transcri
ptional activation domain of Fli-1 which may be the molecular mechanis
m involved in these human tumors.